Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Treatment”

2,951 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,951 results

Not applicableLooking for participantsNCT03390894
What this trial is testing

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Who this might be right for
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group 8,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07192588
What this trial is testing

GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Who this might be right for
Radiodermatitis; Acute
Graegis Pharmaceuticals Ltd 273
Large-scale testing (Phase 3)Ended earlyNCT02664077
What this trial is testing

A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer

Who this might be right for
Stage III (IIIB or IIIC) Colon Cancer
NSABP Foundation Inc 34
Large-scale testing (Phase 3)Ended earlyNCT00003645
What this trial is testing

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 64
Very early researchNot Yet RecruitingNCT06719804
What this trial is testing

Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE)

Who this might be right for
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing 15
Very early researchStudy completedNCT05704933
What this trial is testing

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Who this might be right for
Metastatic MelanomaMetastasis to Brain
H. Lee Moffitt Cancer Center and Research Institute 1
Large-scale testing (Phase 3)UnknownNCT01622361
What this trial is testing

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

Who this might be right for
Breast Cancer
Asan Medical Center 290
Testing effectiveness (Phase 2)Looking for participantsNCT07331883
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 35
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Testing effectiveness (Phase 2)Looking for participantsNCT05536505
What this trial is testing

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

Who this might be right for
MRD
Guangdong Association of Clinical Trials 180
Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Testing effectiveness (Phase 2)WithdrawnNCT04282590
What this trial is testing

Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Toray Industries, Inc
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Not applicableEnded earlyNCT01305239
What this trial is testing

A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients

Who this might be right for
Breast Cancer
Pfizer 398
Testing effectiveness (Phase 2)Study completedNCT01106898
What this trial is testing

Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+1 more
University of Nebraska 112
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Large-scale testing (Phase 3)Looking for participantsNCT05314998
What this trial is testing

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Who this might be right for
Pancreatic Ductal Adenocarcinoma
John Neoptolemos 394
Post-approval studies (Phase 4)Looking for participantsNCT06368063
What this trial is testing

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Xi'an Jiaotong University 642
Next Page